Nova Labs

Executive Summary

Certificate of Analysis (COA) Practices

Status: COA ✓ (third-party lab tested)

COA URL: https://nova-labs.eu/lab-results

Notes: Nova publishes four batch-specific Janoshik reports: CJC-1295 No DAC 10mg batch 2 (task 75543, 9.82mg, 99.804%), Tesamorelin 10mg batch 002 (task 75542, 10.10mg, 99.272%), Retatrutide 10mg batch 005 (task 97361, 10.18mg, 99.596%), and GHK-Cu 50mg batch 5 (task 97360, 45.50mg, 99.356%). Each inspected image includes a Janoshik verification key. Coverage is narrow: the comparison contains 15 variant rows across 12 eligible single-product catalog entries, and only four products have a listed report. The site's claim that randomized testing guarantees the untested catalog is a vendor claim, not batch evidence. Match the received product, strength, batch, task number, and key. Affiliate status does not influence the rating.

Rating Methodology

PeptidePrices rates vendors on a 1–10 scale using a transparent, weighted rubric:

• 40% COA practices — named third-party lab, batch-to-vial linkage, public on-site publication, testing breadth (HPLC purity, mass-spec identity, endotoxin, sterility, heavy metals)
• 20% Community reputation — Trustpilot weighted by review volume, Reddit/forum sentiment, documented red flags
• 20% Transparency — physical address, company age, ownership disclosure, contact info, domain age, return policy
• 20% Operations — shipping speed, customer-service responsiveness, payment flexibility, and dispute handling; affiliate-program performance is not scored

PeptidePrices is independent. No vendor has paid to increase their score. Full methodology at peptideprices.net/trust.